Bhatia Sangeeta N.'s Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 4, 2022
- Accession no.
- 0000899243-22-016638
- Filed
- May 4, 2022
- Trade date
- May 2, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $190.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bhatia Sangeeta N.CIK 0001643921 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | Common Stock | SSaleDisposed | −40 | $255.40 | −$10,216 | 6,600 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −280 | $257.51F2,F3 | −$72,102.8 | 6,320 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −120 | $258.90F2,F4 | −$31,068 | 6,200 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −120 | $259.75F2,F5 | −$31,170 | 6,080 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −80 | $260.82F2,F6 | −$20,865.6 | 6,000 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −91 | $261.91F2,F7 | −$23,833.81 | 5,909 | Direct | |
| May 2, 2022 | Common Stock | SSaleDisposed | −6 | $264.37 | −$1,586.22 | 5,903 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $257.51 (range $257.15 to $258.09).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $258.90 (range $258.32 to $259.19).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $259.75 (range $259.35 to $260.14).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $260.82 (range $260.49 to $261.15).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $261.91 (range $261.69 to $262.09).
Referenced by the price of 1 transaction in Table I.